Real-World Experience of Patients with Sickle Cell Disease Treated with Crizanlizumab: A Single Comprehensive Sickle Cell Center Retrospective Cohort Analysis

Authors
Category Primary study
JournalBlood
Year 2022
This article has no abstract
Epistemonikos ID: 4260cbfbbc4e3847dda84d3113821d28c2e09edd
First added on: Feb 16, 2025